Table 3.
Treatment-related adverse events in breast cancer patients.
| Breast cancer (n = 8), % | ||||||||
|---|---|---|---|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |||||
| Arthralgia | 2 | (25) | 1 | (12.5) | 0 | (0) | 0 | (0) |
| Arthritis | 1 | (12.5) | 0 | (0) | 0 | (0) | 0 | (0) |
| Elevated ALT | 0 | (0) | 0 | (0) | 1 | (12.5) | 0 | (0) |
| Elevated AST | 0 | (0) | 0 | (0) | 1 | (12.5) | 0 | (0) |
| Bone pain | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Bruise at injection site | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Dry mouth | 1 | (12.5) | 0 | (0) | 0 | (0) | 0 | (0) |
| Erythema at chest wall disease | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Erythematous pruritic rash | 1 | (12.5) | 0 | (0) | 0 | (0) | 0 | (0) |
| Fatigue | 0 | (0) | 0 | (0) | 1 | (12.5) | 0 | (0) |
| Fever | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Headache | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Hypothyroidism | 0 | (0) | 2 | (25) | 0 | (0) | 0 | (0) |
| Infusion-related reaction | 0 | (0) | 1 | (12.5) | 0 | (0) | 0 | (0) |
| Injection-site reaction | 7 | (87.5) | 1 | (12.5) | 0 | (0) | 0 | (0) |
| Myalgia | 4 | (50) | 0 | (0) | 0 | (0) | 0 | (0) |
| Pruritus | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Swelling at chest wall disease | 2 | (25) | 0 | (0) | 0 | (0) | 0 | (0) |
| Total | 30 | (78.9) | 5 | (13.2) | 3 | (7.9) | 0 | (0) |
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase.